Table 3.

Management strategies used specifically for treatment of calciphylaxis

Management strategies	Total-89 number (%)
Calcimimetics (cinacalcet)	36 (40.5%)
Sodium thiosulphate	59 (66.3%)
Increased dialysis frequency	17 (19.1%)
Dialysis calcium concentration reduced	20 (22.5%)
Wound debridement	18 (20.2%)
Stopping calcium binders	20 (22.5%)
Stopping/reducing vitamin-D analogues	23 (25.8%)
Stopping warfarin	12 (13.4%)
Bisphosphonates	4 (4.5%)
Antibiotics (intravenous)	27 (30.3%)
Antibiotics (oral)	14 (15.7%)
Hyperbaric oxygen	4 (4.5%)
Skin graft	3 (3.5%)
Amputation	3 (3.5%)

UKCS United Kingdom calciphylaxis study, p-value by chi-square test